DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 29, 2017

Primary Completion Date

February 20, 2024

Study Completion Date

February 20, 2024

Conditions
Skin CancerNon-melanoma Skin CancerSun Damaged SkinActinic Keratosis
Interventions
DRUG

Levulan® Kerastick®

Levulan® Kerastick® for Topical Solution will be applied to a designated area for 3 hours without occlusion prior to illumination with blue light

DRUG

BLU-U Blue Light Photodynamic Therapy

3 hours after Levulan® Kerastick® for Topical Solution is applied blue light illumination of designated area will be performed using the standard FDA approved treatment time of 16 minutes 40 seconds.

Trial Locations (1)

85006

Medical Dermatology Specialists, Phoenix

Sponsors
All Listed Sponsors
collaborator

DUSA Pharmaceuticals, Inc.

INDUSTRY

lead

Medical Dermatology Specialists

OTHER